Short Term Evaluation of the Soothing and Re-epithelizing Activity of Three Topical Products and Relative Combinations
NCT02241161 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2014-09-16
Summary
Aim of the study was to evaluate the soothing and re-epithelizing activity of a single application of topical products on experimentally induced erythema by skin stripping on the forearm (volar surface) of 20 healthy volunteers. In particular the activity of the following three cosmetic products and the relative combinations (cream and serum) were assessed: rejuvenating cream, rejuvenating serum, antioxidant serum
Conditions
- Healthy
Interventions
- OTHER
-
plantaricin a - rejuvenating cream
single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
- OTHER
-
plantaricin a - antioxidant serum
single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
- OTHER
-
plantaricin a - rejuvenating serum
single application on an area of 17,5 cm2, on the forearm, after skin stripping, and left absorbing on the skin for at least 15 minutes
Sponsors & Collaborators
-
Derming SRL
lead OTHER
Principal Investigators
-
Adele Sparavigna, Doctor · Derming SRL
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-12-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin
NCT00601640 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema
NCT05300542 ·Status: COMPLETED ·Phase: NA
-
Twelve Month Follow-Up of CP0108
NCT02209012 ·Status: COMPLETED
-
Daylight-PDT With MAL for AK and Photodamaged Skin
NCT02736760 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage
NCT00629317 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage
NCT02139618 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Madecassoside and 5 % Panthenol Cream in Post Photodynamic Therapy for Actinic Keratosis
NCT05937529 ·Status: COMPLETED ·Phase: NA
-
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Actinic Keratosis
NCT04396184 ·Status: UNKNOWN ·Phase: NA
-
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face
NCT02632110 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy
NCT02239679 ·Status: COMPLETED ·Phase: PHASE2
-
EFFECTIVENESS AND SAFETY OF CREAM CONTAINING SPENT GRAIN WAX EXTRACT, ARGAN OIL, AND SHEA BUTTER POST-TRICHOLOROACETIC ACID 15% PEEL: RANDOMIZED, CONTROLLED, DOUBLE-BLIND, SPLIT-FACE CLINICAL TRIAL
NCT06255431 ·Status: COMPLETED ·Phase: PHASE4
-
Retinol-induced Dermatitis in Aged Skin
NCT00857610 ·Status: COMPLETED
-
TCA 15% Chemical Peel for Improvement in Hand Lentigines
NCT05471947 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With Erythrocouperosis
NCT06824870 ·Status: TERMINATED ·Phase: NA
-
5-ALA Patch-PDT of Actinic Keratosis on the Upper Extremities
NCT03606122 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of IDEA-070 on Pain and Inflammation Induced by PDT
NCT00269074 ·Status: COMPLETED ·Phase: PHASE2
-
Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.
NCT02251756 ·Status: COMPLETED ·Phase: NA
-
Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound
NCT00655512 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease
NCT01912976 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy for Treatment of Lower Extremity Bowen's Disease
NCT03320447 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis
NCT00852137 ·Status: COMPLETED ·Phase: PHASE2
-
PDT vs Peels for Treatment of Actinic Keratoses
NCT04429308 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp
NCT02406014 ·Status: COMPLETED ·Phase: PHASE4
-
Menthol for PDT Pain Relief
NCT02984072 ·Status: COMPLETED ·Phase: PHASE4
-
Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream
NCT04118296 ·Status: COMPLETED ·Phase: PHASE1/PHASE2